The common enemy of Parkinson's, prostate cancer and Alzheimer's

El Heraldo de Aragon and other media have echoed the research headed by Xavier Salvatella, group leader of the Laboratory of Molecular Biophysics at IRB Barcelona. The study, published in ACS Chemical Biology found—contrary to what was believed until now—that disordered regions of proteins can be used as therapeutic targets and that they may have applications on Alzheimer's, Parkinson's and prostate cancer.